Alzheimer’s disease is not contagious. You cannot catch it from a person who has it, whether through casual contact, caregiving, sharing food, or living in the same household. Alzheimer’s is caused by a complex mix of genetics, aging, and environmental factors, not by a virus or bacterium that spreads between people.
That said, some recent research into rare medical scenarios has raised questions about whether the proteins involved in Alzheimer’s can, under very specific laboratory or clinical conditions, be transferred from one person to another. Understanding those findings, and why they don’t change the basic answer, is worth a closer look.
Why Alzheimer’s Is Not an Infectious Disease
Infectious diseases spread when a pathogen (a virus, bacterium, fungus, or parasite) moves from one person to another through air, bodily fluids, surfaces, or other routes. Alzheimer’s doesn’t work this way. It develops when two proteins in the brain, called amyloid-beta and tau, begin to misfold and clump together, gradually damaging and killing neurons over years or decades. This process is driven by a person’s own biology: their genetic makeup, their age, and cumulative environmental exposures like smoking, air pollution, and cardiovascular health.
As the Alzheimer’s Society has stated plainly: “There remains absolutely no evidence that Alzheimer’s disease is contagious.” No case has ever been documented of someone developing the disease through ordinary human contact.
The Misfolded Protein Question
The proteins behind Alzheimer’s do share one unsettling property with prions, the infectious agents responsible for diseases like Creutzfeldt-Jakob disease (CJD). Once amyloid-beta or tau misfolds, it can act as a “seed,” causing nearby normal proteins to misfold and clump in the same way. This chain reaction is how the disease spreads within a single person’s brain, moving from region to region over time.
This prion-like behavior happens inside the brain. It does not mean these proteins jump between people during normal life. The seeding process requires direct contact between the misfolded protein and healthy brain tissue, something that doesn’t occur through breathing, touching, kissing, or sharing a meal.
What the Growth Hormone Cases Showed
A 2024 study in Nature Medicine generated headlines by describing a handful of people who developed Alzheimer’s-related brain changes after receiving growth hormone injections derived from cadaver brains during childhood. This practice, which ended in 1985, accidentally exposed recipients to both CJD prions and amyloid-beta seeds present in the donated tissue.
Of the patients studied, two met clinical and biomarker criteria for Alzheimer’s disease. Others showed some amyloid deposits that didn’t meet the full threshold for an Alzheimer’s diagnosis. The researchers themselves emphasized that these findings do not suggest Alzheimer’s is contagious. What happened was a now-discontinued medical procedure that injected contaminated biological material directly into people’s bodies. Synthetic growth hormone replaced the cadaver-derived version nearly four decades ago.
A related concern involves neurosurgical instruments. A small number of case reports have raised the possibility that traces of misfolded amyloid-beta on reusable surgical tools could theoretically act as seeds if introduced into another patient’s brain tissue. These cases are extraordinarily rare, and no confirmed transmission through modern surgical procedures has been documented. Still, the findings have prompted recommendations for careful sterilization of neurosurgical instruments and, where appropriate, the use of disposable tools.
Can Blood Transfusions Spread Alzheimer’s?
This question has been studied directly. The largest investigation, a retrospective study of nearly 1.5 million transfusion recipients tracked from 1968 to 2012, found no increased risk of Alzheimer’s among people who received blood from donors later diagnosed with dementia. The hazard ratio was 0.99, meaning the risk was essentially identical to that of people who received blood from healthy donors. No disease concordance was found among multiple recipients of the same donor’s blood.
A smaller study in Taiwan did find a modest statistical association between receiving blood transfusions and later developing Alzheimer’s, with about a 37% higher risk compared to controls. However, the study design couldn’t determine whether the transfusion itself caused anything or whether the underlying health conditions that led someone to need a transfusion were the actual risk factor. The weight of evidence does not support blood transfusion as a route of Alzheimer’s transmission.
Proteins in Saliva and Body Fluids
Both amyloid-beta and tau proteins have been detected in saliva, which understandably raises questions for caregivers. Researchers are studying these salivary proteins as potential early screening tools for cognitive decline, not because they pose an infection risk. The proteins are present in extremely small quantities, and there is no evidence that exposure to another person’s saliva, blood, or other body fluids can trigger Alzheimer’s in someone else. The proteins would need to reach brain tissue in sufficient concentration to have any seeding effect, something that doesn’t happen through normal bodily fluid contact.
What Actually Increases Risk
The factors that drive Alzheimer’s risk are well established and have nothing to do with person-to-person transmission. Age is the strongest: risk roughly doubles every five years after age 65. Genetics play a role, particularly a gene variant called APOE4, which increases susceptibility but doesn’t guarantee the disease. Beyond that, the same factors that harm cardiovascular health also raise Alzheimer’s risk: smoking, physical inactivity, poorly managed diabetes, high blood pressure, and chronic exposure to air pollution. These environmental exposures appear to accelerate biological aging in the brain through cumulative damage to cells and DNA over decades.
Head injuries, hearing loss, social isolation, and depression have also been identified as modifiable risk factors. None of these involve catching anything from another person.
Safety for Caregivers
If you’re caring for someone with Alzheimer’s, your health concerns are real, but contagion isn’t one of them. CDC and NIOSH guidelines for dementia caregivers focus entirely on physical safety and emotional well-being, not infection control. The recommendations center on approaching the person calmly, giving them space, and knowing how to respond if agitation escalates. There are no special precautions for handling bodily fluids beyond the standard hygiene you’d practice with anyone.
You can hold hands with, hug, feed, bathe, and share a home with someone who has Alzheimer’s without any risk of developing the disease yourself. The challenges of caregiving are significant, but transmissibility is not among them.